TPIDB > Principal Investigator
Principal Investigator
更新時間：2023-09-19
林靜嫻LIN, CHIN-HSIEN
- Principal Investigator
- Clinical Trial Experience (year) 12 years 9 個月
Publication
25Publications
11
Lin, H. Y., Ou-Yang, C. H., & Lin, C. H. (2020). Reprogramming of a human induced pluripotent stem cell (iPSC) line from a patient with neurodegeneration with brain iron accumulation (NBIA) harboring a novel frameshift mutation in C19orf12 gene. Stem Cell Research, 49, Article 102032. https://doi.org/10.1016/j.scr.2020.102032
12
Lin, H. Y., Tsai, L. K., Cheng, Y. C., Lu, H. E., Huang, C. Y., Hsieh, P. C. H., & Lin, C. H. (2020). Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-048-05) from a patient with ALS and parkinsonism having a hexanucleotide repeat expansion mutation in C9orf72 gene. Stem Cell Research, 44, Article 101734. https://doi.org/10.1016/j.scr.2020.101734
13
Ou-Yang, C. H., Lin, H. Y., Huang, C. Y., & Lin, C. H. (2020). Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-057-05) from a patient with familial parkinsonism and polyneuropathy having a heterozygous p.Y314S mutation in UQCRC1 gene. Stem Cell Research, 49, Article 102031. https://doi.org/10.1016/j.scr.2020.102031
14
Chen, S. J., Lee, N. C., Chien, Y. H., Hwu, W. L., & Lin, C. H. (2019). Heterogeneous nonataxic phenotypes of spinocerebellar ataxia in a Taiwanese population. Brain and Behavior, 9(10), Article e01414. https://doi.org/10.1002/brb3.1414
15
Chen, S. J., Wu, R. M., Ho, C. H., Cheng, J., Lin, H. Y., & Lin, C. H. (2019). Genetic analysis of PODXL gene in patients with familial and young-onset Parkinson's disease in a Taiwanese population. Neurobiology of Aging, 84. https://doi.org/10.1016/j.neurobiolaging.2019.08.027
16
Cheng, Y. C., Lin, H. I., Syu, S. H., Lu, H. E., Huang, C. Y., Lin, C. H., & Hsieh, P. C. H. (2019). Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene. Stem Cell Research, 37, Article 101432. https://doi.org/10.1016/j.scr.2019.101432
17
Kuo, M. C., Lin, H. I., & Lin, C. H. (2019). Craniocervical dystonia with levodopa-responsive parkinsonism co-segregating with a pathogenic ANO3 mutation in a Taiwanese family. Parkinsonism & Related Disorders, 62, 236-238. https://doi.org/10.1016/j.parkreldis.2019.01.020
18
Kuo, Y. C., & Lin, C. H. (2019). Clinical spectrum of glutamic acid decarboxylase antibodies in a Taiwanese population. European Journal of Neurology, 26(11), 1384-1390. https://doi.org/10.1111/ene.14005
19
Lai, C. F., Chen, Y. T., Gu, J., Nerbonne, J. M., Lin, C. H., & Yang, K. C. (2019). Circulating long noncoding RNA DKFZP43410714 predicts adverse cardiovascular outcomes in patients with end-stage renal disease. International Journal of Cardiology, 277, 212-219. https://doi.org/10.1016/j.ijcard.2018.08.013
20
Lin, C. H., Chen, C. C., Chiang, H. L., Liou, J. M., Chang, C. M., Lu, T. P., Chuang, E. Y., Tai, Y. C., Cheng, C., Lin, H. Y., & Wu, M. S. (2019). Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease. Journal of Neuroinflammation, 16, Article 129. https://doi.org/10.1186/s12974-019-1528-y
